<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02964806</url>
  </required_header>
  <id_info>
    <org_study_id>4-2016-0799</org_study_id>
    <nct_id>NCT02964806</nct_id>
  </id_info>
  <brief_title>Development and Clinical Validation of Ketogen-based Therapeutic Diet for Pancreaticobiliary Cancer Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Decreased bowel function and loss of appetite in patients who underwent pancreaticobiliary
      surgery contribute impaired nutritional status in postoperative period. It can also affect
      perioperative and oncologic outcomes negatively. Therefore it is important to improve
      nutritional status in postoperative period by supply tailor-made optimal diets. The
      investigators have developed customized postoperative diets for pancreaticobiliary cancer
      patients. The investigators expect that customized diets for pancreaticobiliary patients will
      increase the food intake rate and contribute a improvement of perioperative outcomes and even
      oncologic outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 7, 2016</start_date>
  <completion_date type="Actual">October 1, 2017</completion_date>
  <primary_completion_date type="Actual">October 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Food Intake Rate(%) for postoperative diet</measure>
    <time_frame>3 days after the diet</time_frame>
    <description>Diet Intake Rate(%) will be examined by dietary satisfaction questionnaires.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Ketogen-based Therapeutic Diet</condition>
  <condition>Pancreaticobiliary Cancer</condition>
  <arm_group>
    <arm_group_label>Ordinary Diet</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Ordinary Diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Modified Atkin's Diet</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Modified Atkin's Diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketogenic Diet</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Ketogenic Diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ordinary Diet</intervention_name>
    <arm_group_label>Ordinary Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Modified Atkin's Diet</intervention_name>
    <arm_group_label>Modified Atkin's Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ketogenic Diet</intervention_name>
    <arm_group_label>Ketogenic Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (age more than 19)

          -  Pancreaticobiliary cancer patient who is scheduled pancreaticoduodenectomy or distal
             pancreatectomy

          -  Pancreatic cancer / Duodenal cancer / Distal bile duct cancer / Ampulla of Vater
             cancer

        Exclusion Criteria:

          -  Patient who denied clinical trial

          -  Diabetes Mellitus(DM) patient with DM complication

          -  Hyperlipidemia patient with vascular co-morbidity

          -  Impaired renal function or renal failure (GFP&lt;90%)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 13, 2016</study_first_submitted>
  <study_first_submitted_qc>November 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2016</study_first_posted>
  <last_update_submitted>March 13, 2018</last_update_submitted>
  <last_update_submitted_qc>March 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

